Sources told Reuters that Aptalis Pharma Inc had appointed lenders to manage its IPO. Aptalis Pharma Inc reportedly hired banks to manage its initial public offering.
Healthcare Health/Fitness
Opsumit approval renews takeover interest in Actelion - analysts
Analysts said the European Commission's approval of Actelion's lung disease drug would have potential investors bid for the Switzerland-based drugmaker.
Authorities grab USD 28 million worth of bitcoins from alleged Silk Road operator
An estimated USD 28 million worth of bitcoins was confiscated by authorities from the computer hardware of Ross William Ulbricht.
Dendreon Corp seeks buyers- sources
Provenge-maker Dendreon Corp was in the process of finding buyers, people with knowledge of the matter told Bloomberg.
McKesson obtains bridge loan
The approval for a bridge loan was given to McKesson to facilitate its acquisition of Celesio AG. The largest pharmaceutical distributor in the United States, McKesson Corp, had recently obtained a USD5.
Latest News
Mckesson's planned bid of Celesio would signal a takeover of the German drug distributor. According to two sources who were familiar with the negotiations, US drugs distributor McKesson was close to offering a deal to German company Celesio.
Cureatr's primary product, a secure messaging app for doctors, received significant backing from investors including Milestone Venture Partners and Cardinal Partners.
Sideris Pharmaceuticals Inc received USD 32 million in capital commitments in its Series A funding round.
President Barack Obama caught a pregnant woman while he was making his speech about the Affordable Care Act in the Rose Garden.
Reckitt Benckiser Group Plc would be reviewing options for its pharmaceutical business, including a potential exit, according to a Bloomberg News report.
Trinity Biotech purchases Lab21's blood bank screening unit for USD7.5 billion. In a recent move, Lab21 had sold its blood bank screening unit to Trinity Biotech for USD7.
The Burman family and Healthcare At Home UK form joint venture for the Indian market. The promoter of Dabur India, the Burman family, is entering into the healthcare market through a joint venture with the founders of UK based 'Healthcare at Home'.
Roche Chief Executive Officer Severin Schwan said the founding families of Roche Holding would prefer to remain independent.
Pharmaceutical firm G1 Therapeutics scored USD 12.5 million from MedImmune Ventures and other investors in its Series A funding round.
